HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Reinhild Klein Selected Research
Reinhild Klein Research Topics
Disease
10
Neoplasms (Cancer)
01/2022 - 09/2010
9
Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 04/2002
6
COVID-19
01/2022 - 11/2020
6
Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 07/2012
5
Liver Diseases (Liver Disease)
01/2013 - 04/2002
4
Infections
01/2022 - 01/2003
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 12/2002
3
Autoimmune Hepatitis
07/2012 - 07/2009
3
Fibromyalgia (Fibrositis)
10/2007 - 02/2002
2
Sclerosing Cholangitis
01/2022 - 05/2018
2
Inflammation (Inflammations)
01/2022 - 02/2012
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 07/2020
2
Rheumatoid Arthritis
11/2020 - 11/2003
2
Thyroiditis
05/2012 - 09/2009
2
Uveitis
02/2012 - 05/2007
2
Connective Tissue Diseases (Connective Tissue Disease)
02/2012 - 09/2007
2
Multiple Sclerosis
02/2011 - 11/2003
2
Hypersensitivity (Allergy)
12/2009 - 10/2007
2
Chronic Hepatitis C
05/2009 - 01/2003
2
Eosinophilia
01/2006 - 12/2002
1
Familial Mediterranean Fever (Periodic Disease)
02/2021
1
Cryopyrin-Associated Periodic Syndromes
02/2021
1
digital ulcers
01/2021
1
Virus Diseases (Viral Diseases)
01/2021
1
Common Cold
01/2021
1
COVID-19 related pediatric multisystem inflammatory disease
11/2020
1
Thrombosis (Thrombus)
11/2020
1
Granuloma
11/2019
1
Testicular Neoplasms (Testicular Cancer)
01/2019
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019
1
Leukemia
01/2019
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018
1
Color Vision Defects (Color Blindness)
12/2017
1
Bronchiolitis Obliterans Syndrome
08/2015
1
Jaundice (Icterus)
01/2014
1
Thymoma (Thymic Carcinoma)
09/2013
1
Myasthenia Gravis
09/2013
1
Hepatitis A (Hepatitis, Infectious)
01/2013
1
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2013
1
Pulmonary Hypertension
07/2012
1
Pulmonary Arterial Hypertension
07/2012
Drug/Important Bio-Agent (IBA)
19
Antibodies
IBA
01/2022 - 02/2002
9
Peptides (Polypeptides)
IBA
01/2022 - 02/2010
8
Autoantibodies
IBA
09/2013 - 11/2003
6
Antigens
IBA
07/2020 - 05/2007
5
Autoantigens
IBA
05/2018 - 06/2005
4
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
01/2022 - 07/2012
4
Epitopes
IBA
01/2021 - 02/2010
3
HLA-DR Antigens (HLA-DR)
IBA
01/2021 - 07/2012
3
Enzymes
IBA
07/2012 - 09/2002
3
Proteins (Proteins, Gene)
FDA Link
02/2012 - 02/2011
2
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
01/2022 - 01/2020
2
Vaccines
IBA
01/2022 - 01/2021
2
Protein Subunit Vaccines
IBA
01/2022 - 11/2019
2
Type I DNA Topoisomerases (Topoisomerase I)
IBA
01/2021 - 07/2018
2
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2021 - 07/2020
2
trioctyl phosphine oxide (TOPO)
IBA
01/2021 - 07/2018
2
anti-scl-70 autoantibodies
IBA
07/2018 - 01/2017
2
Crystallins (Crystallin)
IBA
02/2012 - 05/2007
2
Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)
IBA
02/2010 - 07/2009
2
Lectins
IBA
01/2006 - 12/2002
2
Serotonin (5 Hydroxytryptamine)
IBA
11/2003 - 02/2002
1
COVAC-1 COVID-19 vaccine
IBA
01/2022
1
Monatide (IMS 3015)
IBA
01/2022
1
Toll-Like Receptor 1
IBA
01/2022
1
Interleukin-6 (Interleukin 6)
IBA
01/2022
1
canakinumab
FDA Link
02/2021
1
Colchicine
FDA Link
Generic
02/2021
1
Interleukins
IBA
02/2021
1
Angiotensin II
IBA
01/2021
1
Collagen
IBA
01/2021
1
MHC class I-related chain A
IBA
01/2021
1
mica
IBA
01/2021
1
Oligonucleotides
IBA
11/2020
1
defibrotide
IBA
11/2020
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2020
1
ibrutinib
IBA
01/2020
1
Emulsions
IBA
11/2019
1
Tyrosine Kinase Inhibitors
IBA
01/2019
1
Sulfite Oxidase
IBA
05/2018
1
Lenalidomide (CC 5013)
FDA Link
01/2018
1
Retinaldehyde (Retinal)
IBA
12/2017
1
Cholinergic Receptors
IBA
09/2013
1
Cytokines
IBA
09/2013
1
Immunoglobulins (Immunoglobulin)
IBA
01/2013
1
Adalimumab (Humira)
FDA Link
01/2013
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
01/2013
1
Rituximab (Mabthera)
FDA Link
01/2013
1
Endothelin Receptor Antagonists
IBA
07/2012
1
Endothelin A Receptor
IBA
07/2012
Therapy/Procedure
8
Therapeutics
01/2022 - 12/2002
3
Immunotherapy
01/2019 - 07/2012
2
Hematopoietic Stem Cell Transplantation
07/2020 - 08/2015
2
Stem Cell Transplantation
07/2018 - 01/2017
2
Liver Transplantation
09/2002 - 04/2002
1
Chemoradiotherapy
01/2022
1
Vegan Diet (Diet, Vegan)
11/2020
1
Intravenous Administration
01/2017
1
Off-Label Use
01/2017
1
Aftercare (After-Treatment)
01/2013